Clinical trials for Septic arthritis

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Septic arthritis. For all clinical trials, go to clinical trials search

This list shows clinical trials for Septic arthritis

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Septic arthritis
Title Recruitment status Location
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis Recruiting United Kingdom
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis Recruiting United Kingdom
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Recruiting United Kingdom
A study to investigate what effects FX125L (taken by mouth) has on adults with chronic inflammatory diseases Not Recruiting United Kingdom
Double-blind, triple dummy, parallel-group, randomized, six-month study to compare celecoxib (200 mg BID) with diclofenac SR (75 mg BID) plus omeprazole (20 mg QD) for gastrointestinal events in subjects with osteoarthritis and rheumatoid arthritis at high-risk of gastrointestinal adverse events - Not Applicable Not Recruiting United Kingdom
“Estudio fase III, multicéntrico, randomizado, controlado, doble ciego, con grupos de tratamiento paralelos, para evaluar la seguridad y eficacia de Rituximab en combinación con metotrexato (MTX), en comparación con metotrexato sólo en pacientes con artritis reumatoide activa no tratados previamente con metotrexato” Not Recruiting United Kingdom
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK- 0663/Etoricoxib in Patients with Rheumatoid Arthritis Not Recruiting United Kingdom
Not Recruiting United Kingdom
A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had an inadequate response to methotrexate therapy - Investigating clinical efficacy of ofatumumab in RA patients who had an inadequate response to MTX Not Recruiting United Kingdom
A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had an inadequate response to methotrexate therapy - Investigating clinical efficacy of ofatumumab in RA patients who had an inadequate response to MTX Not Recruiting United Kingdom

Page last reviewed:

Next review due: